A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2014
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Biomarker; Pharmacogenomic
- 10 Jun 2017 Biomarkers information updated
- 11 Jul 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 May 2013 Planned initiation date changed from 1 May 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.